Antibiotic resistance pattern of urine culture isolates from patients with community acquired UTI

 

 

REFERENCES

1. M. M. A. Jebouri and N. Atala, “A Study on the Interrelationship between Renal Calculi, Hormonal Abnormalities and Urinary Tract Infections in Iraqi Patients,” Open Journal of Urology, Vol. 2, No. 1, 2012, pp. 6-10. doi:10.4236/oju.2012.21002
2. Mohemid M. Al-Jebouri, Salih A. Mdish. Antibiotic Resistance Pattern of Bacteria Isolated from Patients of Urinary Tract Infections in Iraq. Open Journal of Urology. 2013; 3: 124-31
3. R. A. Jones, H. I. Inabo and H. B. I. Obanibi. Antimicrobial Susceptibility of Some Urinary Tract Clinical Isolates to Commonly Used Antibiotics. African Journal of Biotechnology.2006; 21(2): 973-78.
4. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicenter Study Group. Eur J Clin Microbiol Infect Dis.2000; 19:112-7.
5. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007; 6:4.
6. S. Manikandan, S. Ganesapandian, M. Singh, et al., “Antimicrobial Susceptibility Pattern of Urinary Tract Infection Causing Human Pathogenic Bacteria,” Asian Journal of Medical Sciences, Vol. 3, No. 2, 2011, pp. 56-60.
7. Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari Cheshmeh M, Salehian Omran D. A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica (Buchar). 2010; 5(2):111–115.
8. Tantry BA, Rahiman S. 2012. Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley West Indian. Med J. 61:703–707.
9. Reis A. C. C., Santos S. R. S., Souza S. C., Saldanha M. G., Pitanga T. N., Oliveira R. R. (2016). Ciprofloxacin resistance pattern among bacteria isolated from patients with community-acquired urinary tract infection. Rev. Inst. Med. Trop. Sao Paulo 58 10.1590/S1678-9946201658053
10. Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015; 15:545.
11. Nandini C, Chandan C, Sinjan G, Mainak M, Ramkrishna B, Kartik P.Pattern of Urinary Antibiograms in a Tertiary Care Hospital of Eastern India.J Assoc Physicians India. 2016;64(5):26-30
12. Gupta V, Yadav A, Joshi RM. Antibiotic resistance pattern in uropathogens. Indian J Med Microbiol. 2002;20:96–98
13. Cunha BA. New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin North Am. 2006;90:1089–1107
14. Brumfitt W, Hamilton-Miller MT. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother. 1998;42:363–371
15. Woodruff MW, Malvin RI, Thompson RI. The renal transport of nitrofurantoin: effect of acid-base balance upon its excretion. JAMA. 1961;175:1132–1135
16. Cunha BA, Comer JB. Pharmacokinetic considerations in the treatment of urinary tract infections. Conn Med. 1979;43:347–353
17. Cunha BA. Nitrofurantoin: current concepts. Urology. 1988;32:67–71
18. Grayson ML, Whitby M. Nitrofurans: nitrofurazone, furazolidone, and nitrofurantoin. In: Grayson ML, Crowe SM, McCarthy JS, et al., editors. , eds. Kucers’ The Use of Antibiotics. 6th ed. London, England: Hodder Arnold; 2010:1195–1204
19. McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc. 2011;86(6):480–488
20. Cunha BA, Schoch PE, Hage JR. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections. Mayo Clin Proc. 2011; 86(12):1243–1244.